Validation and development of MTH1 inhibitors for treatment of cancer
Abstract
Different MTH1 inhibitors have different ability to kill cancer cells. Here we demonstrate that the lack of efficiency of some MTH1 inhibitors is explained by their inability introduce the toxic oxidized nucleotides into DNA. Furthermore, we describe TH1579, Karonudib, which is a potent, selective MTH1 inhibitor with good oral availability and with excellent anti-cancer properties in vivo.BackgroundPreviously, we showed cancer cells rely on the...
Paper Details
Title
Validation and development of MTH1 inhibitors for treatment of cancer
Published Date
Dec 1, 2016
Journal
Volume
27
Issue
12
Pages
2275 - 2283
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History